Nanotechnology in the diagnosis of atherosclerotic disease

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Imaging

Background:

• Atherosclerosis is a chronic inflammatory disease where plaque rupture leads to thrombotic events like heart attack or stroke.
• Cardiovascular events often occur without prior symptoms or significant stenosis, highlighting the need for early diagnostic methods.
• Nanotechnology advancements show promise for molecular imaging and early cardiovascular diagnosis.

Purpose of the Study:

• To review emerging nanotechnologies for early atherosclerosis detection.
• To present methods for identifying vulnerable atherosclerotic plaques using nanotechnology.

Main Methods:

• The review focuses on molecular imaging of atherosclerosis.
• Nanoparticle contrast agents are discussed as a key technology.
• Approaches are categorized by diagnostic imaging modality.

Main Results:

• Nanoparticle-based molecular imaging can detect atherosclerotic disease.
• Targeted nanoparticle agents can identify specific molecular signatures of disease.
• This technology aids in the identification of vulnerable plaques.

Conclusions:

• Nanoparticle contrast agents offer a promising approach for non-invasive atherosclerosis detection.
• Targeted molecular imaging enhances early diagnosis and staging of atherosclerotic disease.
• Improved diagnostic imaging can guide timely interventions and lifestyle modifications.